Bertrand NADEL
PhD
-
Canceropôle PACA Director | Leader of the team "Genomic instability and human hemopathies" at the CIML
CIML, Canceropôle PACA
A therapeutic revolution is happening.
Cancéropôle PACA joins forces with Marseille-Immunopôle to the fight against cancer, through the structuration of ground-breaking platforms and the support of ambitious and strategic academic and translational research programs in the field of anti-tumoral immunotherapy.
A therapeutic revolution is happening.
#researchHave a look on our testimonies
MI COMMUNITY
MI should enable us to accelerate discovery, enhance our treatment options and offer more innovative options to our patients through current clinical trials and those of the future.
Fabrice BARLESI
AP-HM, AMU
MI COMMUNITY
New molecules currently under development at Innate Pharma and in new companies in Marseille reflect the teams' dynamism and local potential.
Norbert VEY
AMU, IPC
MI COMMUNITY
Marseille Immunopole is born from the will of all partners to do even better and progress faster, and thus allow patients always to keep one step ahead of the disease.
Éric VIVIER
AMU, AP-HM, CIML, INNATE PHARMA
MI COMMUNITY
Today, Marseille Immunopôle and their experts and platforms provide an outstanding multidisciplinary scientific environment for thoracic immuno-oncology research.
Céline MASCAUX
AP-HM, AMU
MI AND YOU Show
your commitment to MI
your commitment to MI